New exchange plan enrollees during the first quarter of 2015 spent less on medications than new enrollees during the same time frame 1 year ago
The latest Express Scripts Exchange Pulse Report indicates that new exchange plan enrollees during the first quarter of 2015 spent less on medications than new enrollees during the same time frame 1 year ago—the number of individuals who used at least 1 prescription medication decreased by 18%.
However when examining exchange plan medication trends on a larger scale between March 31, 2014, and March 31, 2015, researchers found this trend to be a positive one. Spending on high-cost specialty medication increased 24% as compared to an 8% growth in traditional health plans.
"While it is encouraging to see data that suggests healthier Americans are enrolling in exchange plans, the research reminds us that many of these patients use this benefit to manage serious, chronic illnesses," Julie Huppert, vice president of healthcare reform at Express Scripts, said in a statement. "Exchange plans have an opportunity to make medications more affordable and accessible by more closely managing the benefit, encouraging the use of home delivery pharmacy and other proven clinical pharmacy programs, which can help boost medication adherence and foster better disease management."
The 15-month analysis that compiled more than 100 million de-identified pharmacy claims also discovered other notable trends, including:
Ms Huppert added that these findings may indicate a new shift in exchange plan trends where more, healthier Americans who use fewer prescription medications will engage in these programs, which can “help the plans achieve a more balanced risk pool.”
Solving the Transition Conundrum as More Children With Muscular Dystrophy Live to Adulthood
March 17th 2025Learning from examples like congenital heart disease and cystic fibrosis can help health systems and clinicians prepare to care for an influx of patients with neuromuscular diseases as they reach adulthood thanks to transformative therapy advances.
Read More
Oz Confirmation Hearing Probes Vision for Medicaid but Coalesces Around Well-Being
March 14th 2025Mehmet Oz, MD, the nominee to lead CMS under the Trump administration, testified in a confirmation hearing before the Senate Finance Committee, where he found common ground on improving outcomes through healthier lifestyle choices but encountered repeated questions on potential Medicaid cuts.
Read More
As Claims Denials Surge, AI and Data-Driven Insights Equip Clinicians, Hospitals to Fight Back
March 13th 2025As health care costs continue to rise and the burden of chronic disease grows, data-driven insights will be essential in shaping the future of patient care, according to experts from Komodo Health and SmarterDx.
Read More
Regenerating Neurons, Muscle, and Hope in the Field of Muscular Dystrophy
March 13th 2025The 2025 Muscular Dystrophy Association Clinical & Scientific Conference, convening in Dallas, Texas, from March 16-18, will feature clinical updates, expert insights, and breaking trial findings that sum up to a new frontier of care for neuromuscular diseases.
Read More